If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Axonics Modulation Technologies"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 16: | Line 16: | ||
[https://www.crunchbase.com/organization/axonics-modulation-technologies Crunchbase] | [https://www.crunchbase.com/organization/axonics-modulation-technologies Crunchbase] | ||
[https://www.linkedin.com/company/axonics/ LinkedIn] | [https://www.linkedin.com/company/axonics/ LinkedIn] | ||
| + | [https://facebook.com/axonics/ Facebook] [https://instagram.com/axonics/ Instagram] | ||
Revision as of 22:45, 21 March 2022
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Founded in The United States around 2012, Axonics Modulation Technologies produces invasive hardware.
Axonics Modulation Technologies makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): PNS
Links
Facebook Instagram